^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

ZG006

i
Other names: ZG006
Associations
Company:
Suzhou Zelgen
Drug class:
CD3 agonist, DLL3 inhibitor
Related drugs:
Associations
2ms
A Phase 1 Dose Escalation Study of ZG006 in Patients with Small Cell Lung Cancer (clinicaltrials.gov)
P1, N=30, Not yet recruiting, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
New P1 trial
|
ZG006
1year
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma (clinicaltrials.gov)
P1/2, N=54, Recruiting, Suzhou Zelgen Biopharmaceuticals Co.,Ltd | Not yet recruiting --> Recruiting
Enrollment open
|
DLL3 (Delta Like Canonical Notch Ligand 3)
|
ZG006
over1year
Study of ZG006 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma (clinicaltrials.gov)
P1/2, N=54, Not yet recruiting, Suzhou Zelgen Biopharmaceuticals Co.,Ltd
New P1/2 trial
|
DLL3 (Delta Like Canonical Notch Ligand 3)
|
ZG006